FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4288474133> ?p ?o ?g. }

• W4288474133 endingPage "494" @default.
• W4288474133 startingPage "483" @default.
• W4288474133 abstract "Nanoparticles (NPs) are of size 1–100 nm and can be made from carbon, metal oxides or organic matter. All NPs have ability to show distinguished physical, biological and chemical properties at nanoscale. NPs exhibit properties like increased reactivity, increased stability in a chemical process, enhanced mechanical strength, dispersion, etc. These gather much attention because of their different and interesting properties, applications and advantages over bulk counterparts. NPs have different size, shape and structure. They can be hollow core, cylindrical, spherical, tubular, spiral, conical, flat or even irregular. They also differ in structure which can range from amorphous to crystalline with one or more crystals. NPs are generally eco-friendly and non-toxic, and hence they are amenable for biomedical applications. Lipopeptides (LPs) are amphiphilic molecules comprising of a lipid associated with the peptide head group. These are self-get together particles which can shape peptide-functionalized supra-atomic nanostructures. The self-get togetherness of LPs encourages the introduction of peptide functionalities at exceptionally high thickness on the outside of nanostructures, for example, fibrils, micelles and vesicles. LPs find use in different industries most important being medicine industry where they are used for preparation of antimicrobial drugs. LPs have shown prominent results in cancer treatment as well. NPs are vastly used in medical industry as a potent drug delivery system. LPs which have property of biosurfactants have capacity to be incorporated in the NPs. Surfactin, a type of LPs, can orchestrate both silver and gold NPs in which this surfactin lipopeptide utilized as a layout or settling operator assumes a key job in the adjustment of the NPs. Gold NPs’ quality is guaranteed by their stability. LPs associated with NPs (LP-NP molecule) can act as important medicinal molecules. A target-specific LP-NP molecule can result in efficient drug delivery, e.g. lipopeptide NPs are among the most potent NPs for the transfer of selective siRNA delivery in non-human primates and rodents. siRNA therapeutic is used for the treatment genetic disorders. Encoding of this siRNA on to the nanoparticle structure of lipopeptide ensures its target drug delivery up to the point of genetic disorder. Antimicrobial properties of the LPs can be explored in to make a target-specific drug in association of NPs. There is vast future of possibility for LP-NP molecules in the medicinal field. In this chapter we will try to address some ongoing research and a futuristic approach in which LP-NP association can result as a boon for medical industry." @default.
• W4288474133 created "2022-07-29" @default.
• W4288474133 creator A5006538669 @default.
• W4288474133 creator A5008054734 @default.
• W4288474133 creator A5086072191 @default.
• W4288474133 date "2022-01-01" @default.
• W4288474133 modified "2023-10-17" @default.
• W4288474133 title "Nanoparticle-Associated Lipopeptides: A New Class of Antimicrobials" @default.
• W4288474133 cites W1471076992 @default.
• W4288474133 cites W1987202454 @default.
• W4288474133 cites W1989721262 @default.
• W4288474133 cites W2014598562 @default.
• W4288474133 cites W2037656506 @default.
• W4288474133 cites W2055361971 @default.
• W4288474133 cites W2057756174 @default.
• W4288474133 cites W2059385820 @default.
• W4288474133 cites W2061073363 @default.
• W4288474133 cites W2082928799 @default.
• W4288474133 cites W2089779264 @default.
• W4288474133 cites W2109843033 @default.
• W4288474133 cites W2116244282 @default.
• W4288474133 cites W2125531748 @default.
• W4288474133 cites W2128089445 @default.
• W4288474133 cites W2165732324 @default.
• W4288474133 cites W2168999294 @default.
• W4288474133 cites W2341527686 @default.
• W4288474133 cites W2602903330 @default.
• W4288474133 cites W2616129231 @default.
• W4288474133 cites W2774011186 @default.
• W4288474133 cites W2796277309 @default.
• W4288474133 cites W2910095434 @default.
• W4288474133 cites W2961807490 @default.
• W4288474133 cites W2979883200 @default.
• W4288474133 cites W2986626038 @default.
• W4288474133 cites W3004841311 @default.
• W4288474133 cites W829504692 @default.
• W4288474133 doi "https://doi.org/10.1007/978-981-16-9232-1_26" @default.
• W4288474133 hasPublicationYear "2022" @default.
• W4288474133 type Work @default.
• W4288474133 citedByCount "1" @default.
• W4288474133 countsByYear W42884741332023 @default.
• W4288474133 crossrefType "book-chapter" @default.
• W4288474133 hasAuthorship W4288474133A5006538669 @default.
• W4288474133 hasAuthorship W4288474133A5008054734 @default.
• W4288474133 hasAuthorship W4288474133A5086072191 @default.
• W4288474133 hasConcept C11268172 @default.
• W4288474133 hasConcept C15083742 @default.
• W4288474133 hasConcept C155672457 @default.
• W4288474133 hasConcept C171250308 @default.
• W4288474133 hasConcept C178790620 @default.
• W4288474133 hasConcept C184651966 @default.
• W4288474133 hasConcept C185592680 @default.
• W4288474133 hasConcept C186187911 @default.
• W4288474133 hasConcept C192562407 @default.
• W4288474133 hasConcept C2776102837 @default.
• W4288474133 hasConcept C2777272437 @default.
• W4288474133 hasConcept C2777425210 @default.
• W4288474133 hasConcept C2779281246 @default.
• W4288474133 hasConcept C2779820397 @default.
• W4288474133 hasConcept C523546767 @default.
• W4288474133 hasConcept C54355233 @default.
• W4288474133 hasConcept C55493867 @default.
• W4288474133 hasConcept C86803240 @default.
• W4288474133 hasConceptScore W4288474133C11268172 @default.
• W4288474133 hasConceptScore W4288474133C15083742 @default.
• W4288474133 hasConceptScore W4288474133C155672457 @default.
• W4288474133 hasConceptScore W4288474133C171250308 @default.
• W4288474133 hasConceptScore W4288474133C178790620 @default.
• W4288474133 hasConceptScore W4288474133C184651966 @default.
• W4288474133 hasConceptScore W4288474133C185592680 @default.
• W4288474133 hasConceptScore W4288474133C186187911 @default.
• W4288474133 hasConceptScore W4288474133C192562407 @default.
• W4288474133 hasConceptScore W4288474133C2776102837 @default.
• W4288474133 hasConceptScore W4288474133C2777272437 @default.
• W4288474133 hasConceptScore W4288474133C2777425210 @default.
• W4288474133 hasConceptScore W4288474133C2779281246 @default.
• W4288474133 hasConceptScore W4288474133C2779820397 @default.
• W4288474133 hasConceptScore W4288474133C523546767 @default.
• W4288474133 hasConceptScore W4288474133C54355233 @default.
• W4288474133 hasConceptScore W4288474133C55493867 @default.
• W4288474133 hasConceptScore W4288474133C86803240 @default.
• W4288474133 hasLocation W42884741331 @default.
• W4288474133 hasOpenAccess W4288474133 @default.
• W4288474133 hasPrimaryLocation W42884741331 @default.
• W4288474133 hasRelatedWork W1541746576 @default.
• W4288474133 hasRelatedWork W1968709827 @default.
• W4288474133 hasRelatedWork W1993198130 @default.
• W4288474133 hasRelatedWork W2143376609 @default.
• W4288474133 hasRelatedWork W2156611380 @default.
• W4288474133 hasRelatedWork W2194181550 @default.
• W4288474133 hasRelatedWork W2618999049 @default.
• W4288474133 hasRelatedWork W2781213482 @default.
• W4288474133 hasRelatedWork W4307154698 @default.
• W4288474133 hasRelatedWork W939059398 @default.
• W4288474133 isParatext "false" @default.
• W4288474133 isRetracted "false" @default.
• W4288474133 workType "book-chapter" @default.